Ulcerative Colitis Medicine Market, Global Outlook and Forecast 2024-2031

Report ID: 1849244 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Ulcerative Colitis Medicine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Ulcerative Colitis Medicine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Ulcerative Colitis Medicine Overall Market Size
    2.1 Global Ulcerative Colitis Medicine Market Size: 2021 VS 2028
    2.2 Global Ulcerative Colitis Medicine Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Ulcerative Colitis Medicine Players in Global Market
    3.2 Top Global Ulcerative Colitis Medicine Companies Ranked by Revenue
    3.3 Global Ulcerative Colitis Medicine Revenue by Companies
    3.4 Top 3 and Top 5 Ulcerative Colitis Medicine Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Ulcerative Colitis Medicine Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Ulcerative Colitis Medicine Players in Global Market
        3.6.1 List of Global Tier 1 Ulcerative Colitis Medicine Companies
        3.6.2 List of Global Tier 2 and Tier 3 Ulcerative Colitis Medicine Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Ulcerative Colitis Medicine Market Size Markets, 2021 & 2028
        4.1.2 5-Aminosalicylic Acid
        4.1.3 Corticosteroids
        4.1.4 Immunomodulator Drugs
        4.1.5 Biologics
    4.2 By Type - Global Ulcerative Colitis Medicine Revenue & Forecasts
        4.2.1 By Type - Global Ulcerative Colitis Medicine Revenue, 2017-2022
        4.2.2 By Type - Global Ulcerative Colitis Medicine Revenue, 2023-2028
        4.2.3 By Type - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Ulcerative Colitis Medicine Market Size, 2021 & 2028
        5.1.2 Ulcerative Proctitis
        5.1.3 Proctosigmoiditis
        5.1.4 Left-Sided Colitis
        5.1.5 Pancolitis
        5.1.6 Acute Severe Ulcerative Colitis
    5.2 By Application - Global Ulcerative Colitis Medicine Revenue & Forecasts
        5.2.1 By Application - Global Ulcerative Colitis Medicine Revenue, 2017-2022
        5.2.2 By Application - Global Ulcerative Colitis Medicine Revenue, 2023-2028
        5.2.3 By Application - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Ulcerative Colitis Medicine Market Size, 2021 & 2028
    6.2 By Region - Global Ulcerative Colitis Medicine Revenue & Forecasts
        6.2.1 By Region - Global Ulcerative Colitis Medicine Revenue, 2017-2022
        6.2.2 By Region - Global Ulcerative Colitis Medicine Revenue, 2023-2028
        6.2.3 By Region - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Ulcerative Colitis Medicine Revenue, 2017-2028
        6.3.2 US Ulcerative Colitis Medicine Market Size, 2017-2028
        6.3.3 Canada Ulcerative Colitis Medicine Market Size, 2017-2028
        6.3.4 Mexico Ulcerative Colitis Medicine Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Ulcerative Colitis Medicine Revenue, 2017-2028
        6.4.2 Germany Ulcerative Colitis Medicine Market Size, 2017-2028
        6.4.3 France Ulcerative Colitis Medicine Market Size, 2017-2028
        6.4.4 U.K. Ulcerative Colitis Medicine Market Size, 2017-2028
        6.4.5 Italy Ulcerative Colitis Medicine Market Size, 2017-2028
        6.4.6 Russia Ulcerative Colitis Medicine Market Size, 2017-2028
        6.4.7 Nordic Countries Ulcerative Colitis Medicine Market Size, 2017-2028
        6.4.8 Benelux Ulcerative Colitis Medicine Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Ulcerative Colitis Medicine Revenue, 2017-2028
        6.5.2 China Ulcerative Colitis Medicine Market Size, 2017-2028
        6.5.3 Japan Ulcerative Colitis Medicine Market Size, 2017-2028
        6.5.4 South Korea Ulcerative Colitis Medicine Market Size, 2017-2028
        6.5.5 Southeast Asia Ulcerative Colitis Medicine Market Size, 2017-2028
        6.5.6 India Ulcerative Colitis Medicine Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Ulcerative Colitis Medicine Revenue, 2017-2028
        6.6.2 Brazil Ulcerative Colitis Medicine Market Size, 2017-2028
        6.6.3 Argentina Ulcerative Colitis Medicine Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Ulcerative Colitis Medicine Revenue, 2017-2028
        6.7.2 Turkey Ulcerative Colitis Medicine Market Size, 2017-2028
        6.7.3 Israel Ulcerative Colitis Medicine Market Size, 2017-2028
        6.7.4 Saudi Arabia Ulcerative Colitis Medicine Market Size, 2017-2028
        6.7.5 UAE Ulcerative Colitis Medicine Market Size, 2017-2028
7 Players Profiles
    7.1 Sumitomo
        7.1.1 Sumitomo Corporate Summary
        7.1.2 Sumitomo Business Overview
        7.1.3 Sumitomo Ulcerative Colitis Medicine Major Product Offerings
        7.1.4 Sumitomo Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.1.5 Sumitomo Key News
    7.2 Pfizer
        7.2.1 Pfizer Corporate Summary
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Ulcerative Colitis Medicine Major Product Offerings
        7.2.4 Pfizer Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.2.5 Pfizer Key News
    7.3 Novartis
        7.3.1 Novartis Corporate Summary
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Ulcerative Colitis Medicine Major Product Offerings
        7.3.4 Novartis Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.3.5 Novartis Key News
    7.4 Merck
        7.4.1 Merck Corporate Summary
        7.4.2 Merck Business Overview
        7.4.3 Merck Ulcerative Colitis Medicine Major Product Offerings
        7.4.4 Merck Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.4.5 Merck Key News
    7.5 Sanofi
        7.5.1 Sanofi Corporate Summary
        7.5.2 Sanofi Business Overview
        7.5.3 Sanofi Ulcerative Colitis Medicine Major Product Offerings
        7.5.4 Sanofi Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.5.5 Sanofi Key News
    7.6 Johnson and Johnson
        7.6.1 Johnson and Johnson Corporate Summary
        7.6.2 Johnson and Johnson Business Overview
        7.6.3 Johnson and Johnson Ulcerative Colitis Medicine Major Product Offerings
        7.6.4 Johnson and Johnson Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.6.5 Johnson and Johnson Key News
    7.7 GSK
        7.7.1 GSK Corporate Summary
        7.7.2 GSK Business Overview
        7.7.3 GSK Ulcerative Colitis Medicine Major Product Offerings
        7.7.4 GSK Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.7.5 GSK Key News
    7.8 AstraZeneca
        7.8.1 AstraZeneca Corporate Summary
        7.8.2 AstraZeneca Business Overview
        7.8.3 AstraZeneca Ulcerative Colitis Medicine Major Product Offerings
        7.8.4 AstraZeneca Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.8.5 AstraZeneca Key News
    7.9 Cipla
        7.9.1 Cipla Corporate Summary
        7.9.2 Cipla Business Overview
        7.9.3 Cipla Ulcerative Colitis Medicine Major Product Offerings
        7.9.4 Cipla Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.9.5 Cipla Key News
    7.10 Sun Pharm
        7.10.1 Sun Pharm Corporate Summary
        7.10.2 Sun Pharm Business Overview
        7.10.3 Sun Pharm Ulcerative Colitis Medicine Major Product Offerings
        7.10.4 Sun Pharm Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.10.5 Sun Pharm Key News
    7.11 Allergan
        7.11.1 Allergan Corporate Summary
        7.11.2 Allergan Business Overview
        7.11.3 Allergan Ulcerative Colitis Medicine Major Product Offerings
        7.11.4 Allergan Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.11.5 Allergan Key News
    7.12 Teva Pharmaceutical
        7.12.1 Teva Pharmaceutical Corporate Summary
        7.12.2 Teva Pharmaceutical Business Overview
        7.12.3 Teva Pharmaceutical Ulcerative Colitis Medicine Major Product Offerings
        7.12.4 Teva Pharmaceutical Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
        7.12.5 Teva Pharmaceutical Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Ulcerative Colitis Medicine Market Opportunities & Trends in Global Market
    Table 2. Ulcerative Colitis Medicine Market Drivers in Global Market
    Table 3. Ulcerative Colitis Medicine Market Restraints in Global Market
    Table 4. Key Players of Ulcerative Colitis Medicine in Global Market
    Table 5. Top Ulcerative Colitis Medicine Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Ulcerative Colitis Medicine Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Ulcerative Colitis Medicine Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Ulcerative Colitis Medicine Product Type
    Table 9. List of Global Tier 1 Ulcerative Colitis Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Ulcerative Colitis Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Ulcerative Colitis Medicine Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Ulcerative Colitis Medicine Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Ulcerative Colitis Medicine Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Ulcerative Colitis Medicine Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Ulcerative Colitis Medicine Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Ulcerative Colitis Medicine Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Ulcerative Colitis Medicine Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Ulcerative Colitis Medicine Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Ulcerative Colitis Medicine Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Ulcerative Colitis Medicine Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Ulcerative Colitis Medicine Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Ulcerative Colitis Medicine Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Ulcerative Colitis Medicine Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Ulcerative Colitis Medicine Revenue, (US$, Mn), 2023-2028
    Table 30. Sumitomo Corporate Summary
    Table 31. Sumitomo Ulcerative Colitis Medicine Product Offerings
    Table 32. Sumitomo Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
    Table 33. Pfizer Corporate Summary
    Table 34. Pfizer Ulcerative Colitis Medicine Product Offerings
    Table 35. Pfizer Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
    Table 36. Novartis Corporate Summary
    Table 37. Novartis Ulcerative Colitis Medicine Product Offerings
    Table 38. Novartis Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
    Table 39. Merck Corporate Summary
    Table 40. Merck Ulcerative Colitis Medicine Product Offerings
    Table 41. Merck Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
    Table 42. Sanofi Corporate Summary
    Table 43. Sanofi Ulcerative Colitis Medicine Product Offerings
    Table 44. Sanofi Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
    Table 45. Johnson and Johnson Corporate Summary
    Table 46. Johnson and Johnson Ulcerative Colitis Medicine Product Offerings
    Table 47. Johnson and Johnson Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
    Table 48. GSK Corporate Summary
    Table 49. GSK Ulcerative Colitis Medicine Product Offerings
    Table 50. GSK Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
    Table 51. AstraZeneca Corporate Summary
    Table 52. AstraZeneca Ulcerative Colitis Medicine Product Offerings
    Table 53. AstraZeneca Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
    Table 54. Cipla Corporate Summary
    Table 55. Cipla Ulcerative Colitis Medicine Product Offerings
    Table 56. Cipla Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
    Table 57. Sun Pharm Corporate Summary
    Table 58. Sun Pharm Ulcerative Colitis Medicine Product Offerings
    Table 59. Sun Pharm Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
    Table 60. Allergan Corporate Summary
    Table 61. Allergan Ulcerative Colitis Medicine Product Offerings
    Table 62. Allergan Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
    Table 63. Teva Pharmaceutical Corporate Summary
    Table 64. Teva Pharmaceutical Ulcerative Colitis Medicine Product Offerings
    Table 65. Teva Pharmaceutical Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Ulcerative Colitis Medicine Segment by Type in 2021
    Figure 2. Ulcerative Colitis Medicine Segment by Application in 2021
    Figure 3. Global Ulcerative Colitis Medicine Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Ulcerative Colitis Medicine Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Ulcerative Colitis Medicine Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Ulcerative Colitis Medicine Revenue in 2021
    Figure 8. By Type - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
    Figure 12. US Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
    Figure 16. Germany Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 17. France Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
    Figure 24. China Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 28. India Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
    Figure 30. Brazil Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
    Figure 33. Turkey Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
    Figure 37. Sumitomo Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Pfizer Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Novartis Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Merck Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Sanofi Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Johnson and Johnson Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. GSK Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. AstraZeneca Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Cipla Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Sun Pharm Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Allergan Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Teva Pharmaceutical Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Ulcerative Colitis Medicine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ulcerative Colitis Medicine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ulcerative Colitis Medicine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports